Related Experiment Video
Updated: Oct 1, 2026

Evaluating Cell Death Signaling by Immunofluorescence in a Rat Model of Ischemic Stroke
Published on: January 3, 2025
Dilated cardiomyopathy in mice deficient for the lysosomal cysteine peptidase cathepsin L
Jörg Stypmann1, Kerstin Gläser, Wera Roth
1Medizinische Klinik und Poliklinik C (Kardiologie und Angiologie), Universitätsklinikum Westfälische Wilhelms-Universität Münster, D-48149 Münster, Germany.
Insights
Cathepsin L deficiency in mice causes dilated cardiomyopathy, leading to enlarged heart chambers, impaired function, and arrhythmias. This highlights the critical role of cathepsin L in maintaining cardiac health.
Area of Science:
- Cardiology
- Molecular Biology
- Genetics
Background:
- Dilated cardiomyopathy (DCM) is a major cause of heart failure with high mortality.
- Myocardial remodeling drives DCM progression, but intracellular proteolysis's role is understudied.
- Lysosomal cysteine proteases are crucial for cellular homeostasis.
Purpose of the Study:
- To investigate the role of lysosomal cysteine peptidase cathepsin L (CTSL) in cardiac morphology and function.
- To elucidate the impact of CTSL deficiency on myocardial remodeling and heart failure development.
Main Methods:
- Utilized CTSL-deficient (knockout) mice model.
- Performed echocardiography for cardiac function assessment.
- Conducted histological and electron microscopy analyses of cardiac tissue.
Main Results:
- CTSL-deficient mice exhibited significant ventricular and atrial enlargement.
- Histology revealed interstitial fibrosis, pleomorphic nuclei, and lysosomal abnormalities in cardiomyocytes.
- Echocardiography showed severely impaired left ventricular function and signs of hypertrophy.
- Cardiac valve insufficiencies and abnormal heart rhythms (tachycardia, extrasystoles, AV block) were observed.
Conclusions:
- CTSL is essential for maintaining normal cardiac morphology and function.
- CTSL deficiency leads to DCM-like phenotype, characterized by structural and functional cardiac deficits.
- Targeting CTSL may offer therapeutic potential for managing dilated cardiomyopathy.
Abstract:
Dilated cardiomyopathy is a frequent cause of heart failure and is associated with high mortality. Progressive remodeling of the myocardium leads to increased dimensions of heart chambers. The role of intracellular proteolysis in the progressive remodeling that underlies dilated cardiomyopathy has not received much attention yet. Here, we report that the lysosomal cysteine peptidase cathepsin L (CTSL) is critical for cardiac morphology and function. One-year-old CTSL-deficient mice show significant ventricular and atrial enlargement that is associated with a comparatively small increase in relative heart weight. Interstitial fibrosis and pleomorphic nuclei were found in the myocardium of the knockout mice. By electron microscopy, CTSL-deficient cardiomyocytes contained multiple large and apparently fused lysosomes characterized by storage of electron-dense heterogeneous material. Accordingly, the assessment of left ventricular function by echocardiography revealed severely impaired myocardial contraction in the CTSL-deficient mice. In addition, echocardiographic and electrocardiographic findings to some degree point to left ventricular hypertrophy that most likely represents an adaptive response to cardiac impairment. The histomorphological and functional alterations of CTSL-deficient hearts result in valve insufficiencies. Furthermore, abnormal heart rhythms, like supraventricular tachycardia, ventricular extrasystoles, and first-degree atrioventricular block, were detected in the CTSL-deficient mice.
Related Concept Videos
Lysosomal Hydrolases
Cardiomyopathy II: Dilated Cardiomyopathy